InsuranceEcosystem MappingCompetitive IntelligenceDue Diligence

Strategic Digital Health decision making and acceleration across Asia Pac

This global Insurer looked to accelerate its Digital Health footprint in Asia, prioritise markets for innovation, and scout for HealthTech ventures that met specific Therapeutic and Category objectives

Strategic question

This global Insurer looked to accelerate its Digital Health footprint in Asia, prioritise markets for innovation, and scout for HealthTech ventures that met specific Therapeutic and Category objectives

How Galen Growth helped

From market signal to decision-ready evidence

Galen Growth combined HealthTech Alpha intelligence with structured ecosystem mapping and competitive intelligence and due diligence to assess the relevant markets, ventures, and evidence against the client's decision criteria.

Outcomes

Working with the insurer’s regional leadership, and country level personnel, we conducted a digital health readiness study in the four markets to establish overall viability of Digital Health. We then analysed each markets HealthTech ecosystem in detail. A key part of the project was enabling the insurer to prioritise which Digital Health categories and therapeutic areas would support their business strategy. We delivered this through analysis of WHO country level disease prevalence data, level of HealthTech investment in different categories, and overall volume of ventures by Therapeutic area
After identifying cardio, oncology and diabetes, as the top health concerns in the four markets, we then delivered a Scouting mission that determined exact HealthTech start ups capable of delivering on the insurer’s strategic objectives around scale and frequency of use

Key results

4Number of countries
3Number of Key TAs analysed
191Number of ventures screened
40Number of ventures shortlisted

Our approach

A repeatable path to a defensible decision

1

Define

Clarify the strategic question, decision owner, market boundaries, and success criteria.

2

Map

Identify the relevant ventures, markets, competitors, partnerships, and evidence signals.

3

Assess

Evaluate maturity, traction, clinical relevance, commercial fit, and operational readiness.

4

Decide

Translate the evidence into a shortlist, benchmark, market view, or portfolio recommendation.